1. Home
  2. VRME vs MBRX Comparison

VRME vs MBRX Comparison

Compare VRME & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.63

Market Cap

10.4M

Sector

Technology

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$3.48

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
MBRX
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
8.6M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
VRME
MBRX
Price
$0.63
$3.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.50
$105.50
AVG Volume (30 Days)
443.8K
629.9K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$3.32
52 Week High
$5.00
$91.25

Technical Indicators

Market Signals
Indicator
VRME
MBRX
Relative Strength Index (RSI) 38.67 47.57
Support Level $0.65 $3.74
Resistance Level $0.67 $4.24
Average True Range (ATR) 0.04 0.54
MACD 0.00 -0.33
Stochastic Oscillator 4.40 4.78

Price Performance

Historical Comparison
VRME
MBRX

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: